home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Ascribe Bioscience recieves $750,000.00 SBIR Phase II award from the National Science Foundation


Ithaca, New York, USA
July 13, 2020

Congrats to Ascribe Bioscience for being awarded a $750,000.00 SBIR Phase II award from NSF. The proposed project seeks to develop a novel control for plant pathogens by leveraging a class of small, naturally occurring molecules that elicit specific immune responses in plants:

Ascribe was founded in 2017 by three BTI scientists, Frank Schroeder, Daniel Klessig and Murli Manohar, and a local entrepreneur, Jay Farmer.
 

Ascribe Bioscience foundersFrank Schroeder, Jay Farmer, Murli Manohar, and Daniel Klessig


Ascribe Bioscience is developing next-generation agrichemicals derived from the naturally-occurring small molecules that mediate interactions between crop plants and the soil microbiome. Their vision is to improve disease resistance in crops using natural compounds that have the potential to dramatically improve agriculture sustainability by reducing dependence on potentially harmful agrochemicals including synthetic fungicides and antibiotics.

 



More news from: Ascribe Bioscience Inc.


Published: July 14, 2020

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section


Copyright @ 1992-2024 SeedQuest - All rights reserved